Literature DB >> 18676959

Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA.

Magalie S Leduc1, Lawrence C Shimmin, Kathy L E Klos, Craig Hanis, Eric Boerwinkle, James E Hixson.   

Abstract

Apolipoprotein H (apoH, also named beta-2 glycoprotein I) is found on several classes of lipoproteins, and is involved in the activation of lipoprotein lipase in lipid metabolism. We have comprehensively investigated the association of variation in the apoH gene (APOH) with lipid traits in hepatic cholesterol transport, dietary cholesterol transport (DCT), and reverse cholesterol transport (RCT). Our study population consisted of families from the Genetic Epidemiology Network of Arteriopathy multicenter study that include African Americans, Mexican Americans, and European Americans. We individually tested 36 single-nucleotide polymorphisms (SNPs) that span the APOH locus, including nonsynonymous variants that result in known apoH charge isoforms. In addition, we constructed haplotypes from SNPs in the 5' promoter region that comprise cis-acting regulatory elements, as well as haplotypes for multiple amino acid substitutions. We found point-wise significant associations of APOH variants with various lipid measures in the three racial groups. The strongest associations were found for DCT traits (triglyceride and apoE levels) in Mexican Americans with a nonsynonymous variant (SNP 14917, Cys306Gly) that may alter apoH protein folding in a region involved in phospholipid binding. In conclusion, family-based analyses of APOH variants have identified associations with measures of lipid metabolism in three American racial groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676959      PMCID: PMC2582370          DOI: 10.1194/jlr.M800155-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  31 in total

1.  Quantitative trait locus mapping using human pedigrees.

Authors:  J Blangero; J T Williams; L Almasy
Journal:  Hum Biol       Date:  2000-02       Impact factor: 0.553

2.  Implementing a unified approach to family-based tests of association.

Authors:  N M Laird; S Horvath; X Xu
Journal:  Genet Epidemiol       Date:  2000       Impact factor: 2.135

3.  Controlling the false discovery rate in behavior genetics research.

Authors:  Y Benjamini; D Drai; G Elmer; N Kafkafi; I Golani
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

4.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

5.  Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.

Authors:  R Schwarzenbacher; K Zeth; K Diederichs; A Gries; G M Kostner; P Laggner; R Prassl
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

6.  A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I.

Authors:  Haider Mehdi; Susan Manzi; Purnima Desai; Qi Chen; Cara Nestlerode; Franklin Bontempo; Stephen C Strom; Reza Zarnegar; M Ilyas Kamboh
Journal:  Eur J Biochem       Date:  2003-01

7.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

Authors:  H P McNeil; R J Simpson; C N Chesterman; S A Krilis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family.

Authors:  Daisuke Takada; Yoichi Ezura; Shuji Ono; Yasuhiko Iino; Yasuo Katayama; Yuanpei Xin; Lily L Wu; Stacey Larringa-Shum; Susan H Stephenson; Steven C Hunt; Paul N Hopkins; Mitsuru Emi
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

9.  A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding.

Authors:  H Mehdi; A Naqvi; M I Kamboh
Journal:  Eur J Biochem       Date:  2000-03

10.  Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Paul R Daniels; Sharon L R Kardia; Craig L Hanis; C Andrew Brown; Richard Hutchinson; Eric Boerwinkle; Stephen T Turner
Journal:  Am J Med       Date:  2004-05-15       Impact factor: 4.965

View more
  9 in total

1.  Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.

Authors:  Graziella E Ronsein; Gissette Reyes-Soffer; Yi He; Michael Oda; Henry Ginsberg; Jay W Heinecke
Journal:  Mol Cell Proteomics       Date:  2015-12-14       Impact factor: 5.911

2.  Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.

Authors:  Fei Song; Anne Poljak; John Crawford; Nicole A Kochan; Wei Wen; Barbara Cameron; Ora Lux; Henry Brodaty; Karen Mather; George A Smythe; Perminder S Sachdev
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

3.  The South Asian genome.

Authors:  John C Chambers; James Abbott; Weihua Zhang; Ernest Turro; William R Scott; Sian-Tsung Tan; Uzma Afzal; Saima Afaq; Marie Loh; Benjamin Lehne; Paul O'Reilly; Kyle J Gaulton; Richard D Pearson; Xinzhong Li; Anita Lavery; Jana Vandrovcova; Mark N Wass; Kathryn Miller; Joban Sehmi; Laticia Oozageer; Ishminder K Kooner; Abtehale Al-Hussaini; Rebecca Mills; Jagvir Grewal; Vasileios Panoulas; Alexandra M Lewin; Korrinne Northwood; Gurpreet S Wander; Frank Geoghegan; Yingrui Li; Jun Wang; Timothy J Aitman; Mark I McCarthy; James Scott; Sarah Butcher; Paul Elliott; Jaspal S Kooner
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

Review 4.  Cardiovascular Disease in South Asian Immigrants: a Review of Dysfunctional HDL as a Potential Marker.

Authors:  Rohan Dod; Aishwarya Rajendran; Mayuri Kathrotia; Amanda Clarke; Sunita Dodani
Journal:  J Racial Ethn Health Disparities       Date:  2022-04-21

5.  Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice.

Authors:  Yaming Liu; Zhe Wu; Yong Zhang; Binbin Chen; Shuqi Yu; Wanyun Li; Jianlin Ren
Journal:  Lipids Health Dis       Date:  2022-09-19       Impact factor: 4.315

6.  Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels-Brief Report.

Authors:  George Thanassoulis; James C Engert; Mary Hoekstra; Hao Yu Chen; Jian Rong; Line Dufresne; Jie Yao; Xiuqing Guo; Michael Y Tsai; Sotirios Tsimikas; Wendy S Post; Ramachandran S Vasan; Jerome I Rotter; Martin G Larson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

7.  Mixed modeling of meta-analysis P-values (MixMAP) suggests multiple novel gene loci for low density lipoprotein cholesterol.

Authors:  Andrea S Foulkes; Gregory J Matthews; Ujjwal Das; Jane F Ferguson; Rongheng Lin; Muredach P Reilly
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

8.  Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.

Authors:  Frédégonde About; Tiphaine Oudot-Mellakh; Jonathan Niay; Pascaline Rabiéga; Vincent Pedergnana; Darragh Duffy; Philippe Sultanik; Carole Cagnot; Fabrice Carrat; Patrick Marcellin; Fabien Zoulim; Dominique Larrey; Christophe Hézode; Hélène Fontaine; Jean-Pierre Bronowicki; Stanislas Pol; Matthew L Albert; Ioannis Theodorou; Aurélie Cobat; Laurent Abel
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

9.  Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.

Authors:  Yitian Zhou; Reedik Mägi; Lili Milani; Volker M Lauschke
Journal:  J Lipid Res       Date:  2018-08-03       Impact factor: 5.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.